Spectral Med Stock Performance
| EDT Stock | CAD 0.53 0.03 6.00% |
The entity has a beta of -0.6, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Spectral Med are expected to decrease at a much lower rate. During the bear market, Spectral Med is likely to outperform the market. At this point, Spectral Med has a negative expected return of -0.35%. Please make sure to validate Spectral Med's total risk alpha and the relationship between the potential upside and market facilitation index , to decide if Spectral Med performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Spectral Med has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Ex Dividend Date 2011-12-19 |
1 | Paul M. Walker Sells 150,000 Shares of Spectral Medical Inc. Stock - MarketBeat | 09/17/2024 |
2 | Spectral AIs Military Medical Device Advances with 7.2M Govt Funding, FDA Breakthrough Status MDAI Stock News - StockTitan | 11/21/2024 |
| Begin Period Cash Flow | 8.4 M |
Spectral |
Spectral Med Relative Risk vs. Return Landscape
If you would invest 69.00 in Spectral Med on August 25, 2024 and sell it today you would lose (16.00) from holding Spectral Med or give up 23.19% of portfolio value over 90 days. Spectral Med is producing return of less than zero assuming 3.567% volatility of returns over the 90 days investment horizon. Simply put, 31% of all stocks have less volatile historical return distribution than Spectral Med, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Spectral Med Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spectral Med's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Spectral Med, and traders can use it to determine the average amount a Spectral Med's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0977
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EDT |
Estimated Market Risk
| 3.57 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Spectral Med is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spectral Med by adding Spectral Med to a well-diversified portfolio.
Spectral Med Fundamentals Growth
Spectral Stock prices reflect investors' perceptions of the future prospects and financial health of Spectral Med, and Spectral Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spectral Stock performance.
| Return On Equity | -9.74 | ||||
| Return On Asset | -0.93 | ||||
| Operating Margin | (9.46) % | ||||
| Current Valuation | 157.55 M | ||||
| Shares Outstanding | 282.82 M | ||||
| Price To Earning | (16.07) X | ||||
| Price To Book | 49.87 X | ||||
| Price To Sales | 78.85 X | ||||
| Revenue | 1.6 M | ||||
| Gross Profit | 983 K | ||||
| EBITDA | (11.2 M) | ||||
| Net Income | (15.51 M) | ||||
| Cash And Equivalents | 3.8 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 8.56 M | ||||
| Debt To Equity | 16.30 % | ||||
| Current Ratio | 6.95 X | ||||
| Book Value Per Share | (0.06) X | ||||
| Cash Flow From Operations | (11.36 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Market Capitalization | 149.89 M | ||||
| Total Asset | 5.21 M | ||||
| Retained Earnings | (125.44 M) | ||||
| Working Capital | (6.12 M) | ||||
About Spectral Med Performance
By examining Spectral Med's fundamental ratios, stakeholders can obtain critical insights into Spectral Med's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Spectral Med is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 142.72 | 165.55 | |
| Return On Tangible Assets | (3.12) | (2.97) | |
| Return On Capital Employed | 2.27 | 2.38 | |
| Return On Assets | (3.01) | (2.86) | |
| Return On Equity | 0.95 | 0.99 |
Things to note about Spectral Med performance evaluation
Checking the ongoing alerts about Spectral Med for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spectral Med help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spectral Med generated a negative expected return over the last 90 days | |
| Spectral Med has some characteristics of a very speculative penny stock | |
| Spectral Med has high historical volatility and very poor performance | |
| Spectral Med has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.6 M. Net Loss for the year was (15.51 M) with profit before overhead, payroll, taxes, and interest of 983 K. | |
| Spectral Med has accumulated about 3.8 M in cash with (11.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Spectral AIs Military Medical Device Advances with 7.2M Govt Funding, FDA Breakthrough Status MDAI Stock News - StockTitan |
- Analyzing Spectral Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spectral Med's stock is overvalued or undervalued compared to its peers.
- Examining Spectral Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spectral Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spectral Med's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spectral Med's stock. These opinions can provide insight into Spectral Med's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Spectral Stock
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.